Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FK778 in liver transplant patients
NCT00451932Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2002
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 12
01
Overview
Phase 2, randomised, double-blind trial of manitimus in liver transplantation, sponsored by Astellas Pharma. Primary endpoint: Biopsy-proven acute rejection. Started Oct 2002; status: completed.
02
Drugs
manitimus
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT00451932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451932.